September 16, 2014 8:56 PM ET

Pharmaceuticals

Company Overview of Angiogenix, Inc.

Executive Profile

Uri Elkayam M.D.

Member of the Clinical Advisory Board, Angiogenix, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Uri Elkayam, MD serves as a Member of Clinical Advisory Board of Angiogenix Inc. Dr. Elkayam is Professor of Medicine and Director of the Heart Failure Program at the University of Southern California. Dr. Elkayam trained at the University of Vienna and received his medical degree from Sackler School of Medicine in Tel Aviv. His research interests include congestive heart failure, vascular biology, cardiovascular pharmacology, and nitrate tolerance. He has been on the ...

Corporate Headquarters

500 Airport Boulevard
Burlingame, California 94010

United States

Phone: 650-579-6685
Fax: 650-579-6635

Board Members Memberships

There is no Board Members Memberships data available.

Education

Unknown/Other Education
Universitat Wien
MD
Sackler School of Medicine, Israel

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Angiogenix, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.